GW PHARMACEUTICALS PLC Pre-Tax Income
GW PHARMACEUTICALS PLC reported Pre-Tax Income of -$21.74 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2021-05-03
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-03-31 was -$21.74M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-12-31 was -$26.54M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-09-30 was -$14.58M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-06-30 was -$7.70M, a 109.76% decline year-over-year.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$55.05M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$9.20M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$291.37M.
- GW PHARMACEUTICALS PLC income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$171.49M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$21.74M 10-Q · filed 2021-05-03 | -$48.28M derived: sum of 2 quarters · filed 2021-05-03 | -$62.86M derived: sum of 3 quarters · filed 2021-05-03 | -$70.56M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | -$26.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$41.12M derived: sum of 2 quarters · filed 2021-02-26 | -$48.82M derived: sum of 3 quarters · filed 2021-02-26 | -$55.05M 10-K · filed 2021-02-26 |
| 2020-09-30 | -$14.58M 10-Q · filed 2020-11-05 | -$22.28M derived: sum of 2 quarters · filed 2020-11-05 | -$28.51M 10-Q · filed 2020-11-05 | -$52.15M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$7.70M 10-Q · filed 2020-08-07 | -$13.93M 10-Q · filed 2020-08-07 | -$37.57M derived: sum of 3 quarters · filed 2021-05-03 | -$51.37M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$6.23M 10-Q · filed 2021-05-03 | -$29.87M derived: sum of 2 quarters · filed 2021-05-03 | -$43.66M derived: sum of 3 quarters · filed 2021-05-03 | $35.20M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$23.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$37.44M derived: sum of 2 quarters · filed 2021-02-26 | $41.43M derived: sum of 3 quarters · filed 2021-02-26 | -$9.20M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$13.79M 10-Q · filed 2020-11-05 | $65.07M derived: sum of 2 quarters · filed 2020-11-05 | $14.44M 10-Q · filed 2020-11-05 | -$57.73M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $78.86M 10-Q · filed 2020-08-07 | $28.23M 10-Q · filed 2020-08-07 | -$43.94M derived: sum of 3 quarters · filed 2021-02-26 | -$124.38M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$50.63M 10-Q · filed 2020-05-11 | -$122.80M derived: sum of 2 quarters · filed 2021-02-26 | -$203.25M derived: sum of 3 quarters · filed 2021-02-26 | -$287.63M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$72.17M 10-K · filed 2021-02-26 | -$152.62M derived: sum of 2 quarters · filed 2021-02-26 | -$237.00M derived: sum of 3 quarters · filed 2021-02-26 | -$305.44M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | -$80.44M 10-Q · filed 2019-11-06 | -$164.82M derived: sum of 2 quarters · filed 2019-11-06 | -$233.27M 10-Q · filed 2019-11-06 | -$291.37M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$84.38M 10-Q · filed 2019-08-07 | -$152.83M 10-Q · filed 2019-08-07 | -$210.93M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | -$68.45M 10-Q · filed 2019-05-08 | -$126.55M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | -$58.10M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | -$171.49M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | -$92.39M 10-KT · filed 2019-02-28 |